Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 237

1.

MicroRNA-195 protects against dementia induced by chronic brain hypoperfusion via its anti-amyloidogenic effect in rats.

Ai J, Sun LH, Che H, Zhang R, Zhang TZ, Wu WC, Su XL, Chen X, Yang G, Li K, Wang N, Ban T, Bao YN, Guo F, Niu HF, Zhu YL, Zhu XY, Zhao SG, Yang BF.

J Neurosci. 2013 Feb 27;33(9):3989-4001. doi: 10.1523/JNEUROSCI.1997-12.2013.

2.

Activation of Cdk5/p25 and tau phosphorylation following chronic brain hypoperfusion in rats involves microRNA-195 down-regulation.

Sun LH, Ban T, Liu CD, Chen QX, Wang X, Yan ML, Hu XL, Su XL, Bao YN, Sun LL, Zhao LJ, Pei SC, Jiang XM, Zong DK, Ai J.

J Neurochem. 2015 Sep;134(6):1139-51. doi: 10.1111/jnc.13212.

PMID:
26118667
3.

MicroRNA-384 regulates both amyloid precursor protein and β-secretase expression and is a potential biomarker for Alzheimer's disease.

Liu CG, Wang JL, Li L, Wang PC.

Int J Mol Med. 2014 Jul;34(1):160-6. doi: 10.3892/ijmm.2014.1780. Epub 2014 May 13.

PMID:
24827165
4.

Dexamethasone and Aβ₂₅-₃₅ accelerate learning and memory impairments due to elevate amyloid precursor protein expression and neuronal apoptosis in 12-month male rats.

Li WZ, Li WP, Huang DK, Kan HW, Wang X, Wu WY, Yin YY, Yao YY.

Behav Brain Res. 2012 Feb 1;227(1):142-9. doi: 10.1016/j.bbr.2011.10.038. Epub 2011 Oct 29.

PMID:
22061800
5.

Ginsenoside Rg1 attenuates β-amyloid generation via suppressing PPARγ-regulated BACE1 activity in N2a-APP695 cells.

Chen LM, Lin ZY, Zhu YG, Lin N, Zhang J, Pan XD, Chen XC.

Eur J Pharmacol. 2012 Jan 30;675(1-3):15-21. doi: 10.1016/j.ejphar.2011.11.039. Epub 2011 Dec 7.

PMID:
22166376
6.

MicroRNA-195 downregulates Alzheimer's disease amyloid-β production by targeting BACE1.

Zhu HC, Wang LM, Wang M, Song B, Tan S, Teng JF, Duan DX.

Brain Res Bull. 2012 Sep 1;88(6):596-601. doi: 10.1016/j.brainresbull.2012.05.018. Epub 2012 Jun 19.

PMID:
22721728
8.
9.

Decrease in brain soluble amyloid precursor protein β (sAPPβ) in Alzheimer's disease cortex.

Wu G, Sankaranarayanan S, Hsieh SH, Simon AJ, Savage MJ.

J Neurosci Res. 2011 Jun;89(6):822-32. doi: 10.1002/jnr.22618. Epub 2011 Mar 23.

PMID:
21433051
10.

Regulation of β-amyloid level in the brain of rats with cerebrovascular hypoperfusion.

Liu H, Xing A, Wang X, Liu G, Li L.

Neurobiol Aging. 2012 Apr;33(4):826.e31-42. doi: 10.1016/j.neurobiolaging.2011.05.027. Epub 2011 Aug 3.

PMID:
21813211
11.

Upregulation of BACE1 and beta-amyloid protein mediated by chronic cerebral hypoperfusion contributes to cognitive impairment and pathogenesis of Alzheimer's disease.

Zhiyou C, Yong Y, Shanquan S, Jun Z, Liangguo H, Ling Y, Jieying L.

Neurochem Res. 2009 Jul;34(7):1226-35. doi: 10.1007/s11064-008-9899-y. Epub 2009 Jan 4.

PMID:
19123057
12.

Control of BACE1 degradation and APP processing by ubiquitin carboxyl-terminal hydrolase L1.

Zhang M, Deng Y, Luo Y, Zhang S, Zou H, Cai F, Wada K, Song W.

J Neurochem. 2012 Mar;120(6):1129-38. doi: 10.1111/j.1471-4159.2011.07644.x. Epub 2012 Feb 10.

13.

Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.

Rockenstein E, Torrance M, Mante M, Adame A, Paulino A, Rose JB, Crews L, Moessler H, Masliah E.

J Neurosci Res. 2006 May 15;83(7):1252-61.

PMID:
16511867
14.

Protective role of luteolin against cognitive dysfunction induced by chronic cerebral hypoperfusion in rats.

Fu X, Zhang J, Guo L, Xu Y, Sun L, Wang S, Feng Y, Gou L, Zhang L, Liu Y.

Pharmacol Biochem Behav. 2014 Nov;126:122-30. doi: 10.1016/j.pbb.2014.09.005. Epub 2014 Sep 16.

PMID:
25220684
15.

Glucocorticoids facilitate astrocytic amyloid-β peptide deposition by increasing the expression of APP and BACE1 and decreasing the expression of amyloid-β-degrading proteases.

Wang Y, Li M, Tang J, Song M, Xu X, Xiong J, Li J, Bai Y.

Endocrinology. 2011 Jul;152(7):2704-15. doi: 10.1210/en.2011-0145. Epub 2011 May 10.

PMID:
21558319
16.

Ryanodine receptor blockade reduces amyloid-β load and memory impairments in Tg2576 mouse model of Alzheimer disease.

Oulès B, Del Prete D, Greco B, Zhang X, Lauritzen I, Sevalle J, Moreno S, Paterlini-Bréchot P, Trebak M, Checler F, Benfenati F, Chami M.

J Neurosci. 2012 Aug 22;32(34):11820-34.

17.

[Effects of huannao yicong recipe extract on the learning and memory and related factors of Abeta generation in the brain of APP transgenic mice].

Li H, Liu MF, Liu JG, Liu LT, Guan J, Cai LL, Hu J, Wei Y.

Zhongguo Zhong Xi Yi Jie He Za Zhi. 2013 Jan;33(1):90-4. Chinese.

PMID:
23596795
18.

Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model.

Durairajan SS, Liu LF, Lu JH, Chen LL, Yuan Q, Chung SK, Huang L, Li XS, Huang JD, Li M.

Neurobiol Aging. 2012 Dec;33(12):2903-19. doi: 10.1016/j.neurobiolaging.2012.02.016. Epub 2012 Mar 27.

PMID:
22459600
19.

Synaptic and cognitive improvements by inhibition of 2-AG metabolism are through upregulation of microRNA-188-3p in a mouse model of Alzheimer's disease.

Zhang J, Hu M, Teng Z, Tang YP, Chen C.

J Neurosci. 2014 Nov 5;34(45):14919-33. doi: 10.1523/JNEUROSCI.1165-14.2014.

20.

Phosphorylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogenesis.

O'Connor T, Sadleir KR, Maus E, Velliquette RA, Zhao J, Cole SL, Eimer WA, Hitt B, Bembinster LA, Lammich S, Lichtenthaler SF, Hébert SS, De Strooper B, Haass C, Bennett DA, Vassar R.

Neuron. 2008 Dec 26;60(6):988-1009. doi: 10.1016/j.neuron.2008.10.047.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk